In most telehealth programmes the second and third cycles decide profitability, not the first. Retention marketing is the operating layer that gets patients there — and the cohort reporting that shows you where they stop.
Request a Retention ReviewTelehealth retention marketing is the set of lifecycle programmes that keep an active patient engaged with their care plan: onboarding, expectation setting, adherence support, refill and renewal prompts, service recovery, and win-back. It sits after the consultation and runs for as long as the relationship does.
It is not a newsletter. Retention work is measured in cohorts — what share of patients who started in a given month are still active at 30, 60, 90, and 180 days — and it is judged on whether that curve moves.
Retention work pays back fastest for programmes where care is ongoing rather than one-off.
Recurring-revenue programmes where a single cancelled cycle removes most of the margin on an expensive acquisition.
Weight management, hormone therapy, and similar categories where clinical results take months and early drop-off is driven by unmet expectations rather than dissatisfaction with the product.
Any model where continuing requires a patient action — reordering, re-consulting, or renewing — and that action is currently unassisted.
When acquisition costs climb, the only durable response is to earn more cycles per patient. Retention becomes the cheaper growth lever well before it becomes the obvious one.
Early churn is usually an expectation problem. Patients who were never told what the first weeks feel like, how long results take, or what to do about a side effect quietly stop — and they stop before anyone in the business has a reason to contact them.
Renewal messaging is often keyed to a billing date rather than to where the patient is in their plan. The message arrives after the patient has already lapsed, or so far ahead of the decision that it is ignored.
A monthly churn percentage hides everything actionable. Without cohort curves you cannot tell an onboarding failure from a month-three plateau, and the two require completely different interventions.
Sequenced so that the largest measured loss is addressed first.
We build the retention curve by start cohort and by acquisition channel. This normally reveals that a specific channel or programme is producing patients who leave early, which is an acquisition finding as much as a retention one.
A structured first-30-days sequence covering what to expect, when results typically appear, how to reach support, and what warrants contacting the provider. Educational only — clinical guidance stays with the clinical team.
Lightweight check-ins timed to the points where the cohort data shows patients disengage, with clear escalation into the clinical team when a patient reports something that needs a clinician.
Prompts keyed to the patient plan rather than the invoice, with a frictionless path back to a provider where a new consultation is required, and recovery for failed payments and lapsed refills.
Segmented outreach to lapsed patients based on why they left and how long ago, with suppression rules so the people who asked not to be contacted are not contacted.
Retention content is where marketing most easily drifts into clinical territory. Our rule is simple: lifecycle messaging can set expectations, explain the programme, prompt an action, and route a patient to their provider. It cannot interpret symptoms, advise on dosing, or discourage someone from stopping a treatment their clinician has questions about.
Escalation paths are defined with the clinical team before any sequence goes live, and messaging that touches a clinical topic is reviewed by them, not by us alone.
Retention runs on channels with their own consent requirements. SMS, email, and push each carry separate permission, preference, and opt-out obligations, and a lapsed patient does not become re-contactable because they lapsed. Suppression and preference state are maintained centrally so a win-back campaign cannot override an opt-out.
Retention is reported as curves and cohorts, never as a single blended rate.
The first artefact is your own cohort curve. In most engagements it is the first time the business has seen retention split by start month and acquisition channel at the same time, and it usually reorders the priority list on its own.
We report against that baseline. Any figure we quote from other engagements carries its vertical, date range, baseline, and result definition, with the caveat that retention varies heavily by programme and clinical category.
When the cohort curve drops steeply in the first cycle, or when cost per acquired patient has risen to the point where a single cycle no longer covers it. Both are measurable. If most patients leave before the second cycle, additional acquisition spend is buying churn at full price.
Retention programmes are marketing and operational communications, not medical advice. Clinical guidance and escalation remain with the client's licensed providers. Digital Wellness Partners is not a healthcare provider, pharmacy, or law firm.
Written by Simeon Krastev · Last reviewed August 7, 2026
We build the cohort baseline from your own data and show you where in the lifecycle patients are actually leaving.
Request a Retention Review